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INTRODUCTION 
The endogenous neuropeptide nociceptin (N/OFQ) and its 
receptor, the nociceptin receptor (NOP1), are highly expressed 
in the hippocampus, where they regulate learning and memory 
by inhibiting synaptic transmission and plasticity. The L-type 
calcium channel (LTCC) Cav1.2 is also expressed in the 
hippocampus and is one of the major sources of Ca2+ in the 
postsynaptic compartment of neurons. Activation of Cav1.2 
regulates memory and learning-associated biochemical 
changes through activation of cAMP response element-
binding protein (CREB) and NMDA receptor-independent 
long-term potentiation (LTP) [1]. It has previously been 
shown that activation of NOP1 receptor by nociceptin 
downregulates LTCCs as well as other voltage gated calcium 
channels in hippocampal neurons [2], but little is known 
regarding the molecular mechanisms of this modulation. 
METHODS 
Co-immunoprecipitations were performed with transfected 
tsA-201cells and mouse hippocampal lysates. Cultured rat 
hippocampal neurons 10 days in-vitro were used to perform 
calcium imaging experiments using the Fluo-4AM dye and for 
confocal imaging of immunocytochemically stained cells for 
p-CREB and MAP2.  
RESULTS 
We show that Cav1.2 and NOP1 receptor form a complex and 
co-immunoprecipitate from transfected tsA201 cells and from 
hippocampal brain tissue. Calcium imaging of cultured rat 
hippocampal neurons treated with nociceptin (1uM) and 
depolarized with 40mM KCl revealed a significant decrease in 
calcium influx. Treatment with the LTCC blocker, Nifedipine 
showed that calcium influx is partially mediated by Cav1.2. 
Subsequent imaging of cultured rat hippocampal neurons 
treated with nociceptin (100nM) and depolarized with 40mM 
KCl revealed a significant decrease in CREB phosphorylation 
in the nucleus, an important step for neuronal plasticity. 
Treatments with Nifedipine and NMDA receptor antagonists 
(MK-801 and APV) indicate that the activation of nuclear p-
CREB results in part from the activation of Cav1.2, and is 
NMDA receptor-independent. 
 
Figure 1. Nuclear p-CREB intensity as a function of drug and 
stimulatory treatment in cultured rat hippocampal neurons. 
Values represent the mean ± SEM. Sample size is indicated 
above each respective bar in parentheses (1-way ANOVA with 
Tukey post-hoc comparison, ****p<0.0001). Representative 
images of each treatment are listed below.  
DISCUSSION AND CONCLUSIONS 
Nociceptin and its receptor, NOP1, modulate the LTCC 
Cav1.2 and its downstream effects in the excitation-
transcription pathway. Our data provide novel insights into the 
mechanisms by which the endogenous neuropeptide 
nociceptin affects hippocampal neuron function. Ultimately, 
this could identify new strategies for the alleviation of 
memory disorders. Further studies are being conducted to 
characterize the mode of Cav1.2 modulation and changes in its 
intrinsic properties. 
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